BMY vs MAS · P/E 17, rev $24.46B vs P/E 18, rev $7.56B
Bristol-Myers Squibb Company (BMY) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the BMY and MAS stock pages for the full models.
Not investment advice.